To Evaluate How the Outcome of Neuroendocrine Tumour (NET) Multidisciplinary Team (MDT) Meeting Decisions Are Conveyed to Patients at a ENETS Centre of Excellence (The Christie) and How This Service Can Be Further Improved

Christina Rigby, Wasat Mansoor, Juan Valle, Richard Hubner, Mairead Mcnamara

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

Introduction: It is recommended that people with cancer should be managed
by an MDT and the outcomes should be communicated in a “timely manner”.
However, it does not specify when this should be done, or by whom. Aim(s):
To review how MDT recommendations were communicated at a ENETs
Centre of Excellence. Materials and methods: In this single-centred
retrospective study, case-notes of 55 patients who had been discussed at the
NET MDT (April-June 2015) were reviewed. Results: All MDT
recommendations were documented in case-notes within 7 days of the MDT;
62% of patients were informed of the outcome: of these, 88% were informed in
clinic. Patients were informed by a Consultant (33%), Senior doctors (46%) or
the Nurse Clinician (21%). Of the 62%, 94% had been informed of the MDT
outcome within 14 days (median time: 6 days [range 0-21]). Thirty-four
percent of General Practitioners (GPs) were informed; of these, 78% received
communication within 8 days (range 0-28). Ninety-four percent of the
recommended actions from the MDT were conducted within 14 days (median
time: 5 days [range 0-60]). Conclusion: Compliance of case-note
documentation and ensuring MDT recommendations were actioned within 2
weeks was above 90%. In most cases, patients were informed of the MDT
outcome during a clinic consultation by a member of the NET team. There
was evidence that only 62% of patients and 33% of GPs were informed of the
MDT outcome, therefore greater attention to communication and
documentation of this communication is required.
Original languageEnglish
Title of host publicationNeuroendocrinology
Pages119-119
Number of pages1
Volume103
Publication statusPublished - Mar 2016

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Fingerprint

Dive into the research topics of 'To Evaluate How the Outcome of Neuroendocrine Tumour (NET) Multidisciplinary Team (MDT) Meeting Decisions Are Conveyed to Patients at a ENETS Centre of Excellence (The Christie) and How This Service Can Be Further Improved'. Together they form a unique fingerprint.

Cite this